Return on Open Innovation Investment KPI

Return on Open Innovation Investment (ROOII) measures the effectiveness of investments in collaborative innovation initiatives.

This KPI is crucial for understanding how well organizations leverage external ideas to drive product development and operational efficiency.

A high ROOII indicates successful partnerships and strategic alignment with market needs, leading to enhanced business outcomes.

Conversely, a low ROOII may signal misalignment or ineffective collaboration strategies.

Organizations can use this metric to optimize resource allocation and improve forecasting accuracy.

Tracking ROOII helps ensure that innovation efforts contribute positively to financial health and long-term growth.

How Return on Open Innovation Investment Connects to Your Strategy

Return on Open Innovation Investment belongs to one KPI group in KPI Depot: Open Innovation Programs. That group holds forty-five metrics and this one ranks second, behind Open Innovation Revenue Contribution.

The shape of the top of that ranking is worth a moment. The three leading members are all financial: Open Innovation Revenue Contribution, this ratio, then Market Share of Open Innovation Products. Below them the perspective changes. Investment in Open Innovation, Number of Patents from Open Innovation, External Ideas Adopted and Quality of Open Innovation Submissions carry the growth perspective, and Speed to Market for Open Innovation Projects carries the internal one. So a discipline usually discussed in terms of partners, ideas and patents has a KPI group that puts money in the first three slots. The reason is structural. Open innovation moves cash and IP to parties outside the company, under contracts, and a program that cannot state what it returned gets renewed on goodwill until the year goodwill runs out.

The balanced scorecard placement fixes the timing. A financial metric confirms rather than predicts. Everything that moves this ratio was settled earlier: which partners were signed, what the agreements conceded on ownership and revenue share, whether the joint work reached a market, and how much internal time the collaboration consumed on the way. By the time the ratio is calculable, the decisions it judges are old.

The KPI group's own sequencing advice is revealing here, because this metric is not in it. That advice starts with Investment in Open Innovation, on the grounds that it is typically well documented, then Open Innovation Project Completion Rate for execution risk, then Open Innovation Revenue Contribution to quantify outcomes. This ratio needs both ends of that sequence at once: its denominator is essentially the first metric and its numerator depends on the third. Customers who try to stand it up first end up estimating both halves, and two estimates divided by each other is not a measurement.

The sharpest tension in this KPI group runs to Investment in Open Innovation at priority four, and it is a direct one. The KPI group places that metric in the growth perspective, where a rising number reads as commitment to the program and a falling one reads as retreat. This metric divides by it. The same program can be asked to grow its open innovation spend as evidence of ambition and to raise a ratio that gets worse every time the spend rises ahead of realized gains, which it always does, because spend lands first. Anyone running both as targets in the same period should say out loud which one yields.

A second tension runs to Open Innovation Revenue Contribution at priority one. A total grows by doing more; a ratio is diluted by the marginal partnership. A program that pursues every collaboration worth pursuing will post a weaker ratio than one that runs only the obvious winners and stops, and the second program leaves value uncollected. The two metrics also count different money. Revenue contribution is a top line, while this metric's numerator is a gain net of what the collaboration cost, and co-created products carry partner economics: royalties, revenue share, joint ownership. A product can add meaningfully to Open Innovation Revenue Contribution and contribute far less here after the partner's share is honored.

Number of Patents from Open Innovation at priority five and Market Share of Open Innovation Products at priority three create the same problem from the other side. The KPI group flags the pattern itself: rising patents with stagnant market share points to a commercialization bottleneck. In this ratio that pattern is a denominator growing on a filing schedule while the numerator waits for a license, a product launch or an infringement settlement that may be years out. Patents are cost first and value later, and the gap between the two is exactly where this metric misreads a healthy pipeline as a failing one.

That leaves Speed to Market for Open Innovation Projects at priority six, the one internal metric near the top, as the mechanism that decides whether any gain lands inside the window the ratio covers. Compress it and returns move into the period that is already carrying their cost. The KPI group's guidance on Quality of Open Innovation Submissions at priority eight works on the same seam from the intake side: screening harder keeps External Ideas Adopted at priority seven from becoming a count of adoptions that each carry evaluation, contracting and coordination cost while few of them ever reach the numerator.

Measuring Return on Open Innovation Investment in Practice

The formula is gains from open innovation less the cost of open innovation, divided by that cost. The denominator is scattered across systems that belong to other functions, and the numerator is an argument someone has to make and defend. Neither side is a query.

Start with where the cost actually sits, because most programs underestimate it by construction. Partner fees, challenge and prize awards, accelerator and consortium memberships and sponsored research payments are in accounts payable, often under cost centers owned by business units rather than by the innovation team. Licensing-in payments sit in a contracts register with their own renewal calendar. Equity taken in a startup partner sits with corporate development and on the balance sheet, not in any innovation budget. Legal and IP cost arrives as outside counsel invoices, filing fees and docket charges, usually routed to legal. Internal coordination time is the item that is nowhere at all: the engineer who runs the technical exchange, the product manager who translates between two plans, the procurement and compliance work on a joint development agreement. Nobody charges a code for hosting a partner. A denominator assembled from the innovation budget alone will capture the first category and miss most of the rest, and the missed categories are the ones that grow fastest as a program scales.

The numerator comes from different places and different kinds of evidence. Incremental margin on a co-developed product is in the product ledger. License and royalty income is in the royalty ledger. Cost taken out of a process by an external solution exists only as an engineering estimate. The join between the two halves runs on product or project identifiers, and that join is where honesty is decided, because a co-developed product has one identifier and several parents, each of which will claim it.

Settle these forks before the first calculation, and record the answers where the next person inherits them.

• What Counts as a Gain, and When It Is Realized. Incremental margin on a co-created product, license income from IP that came out of a collaboration, cost removed from an existing process by an external solution, and capability acquired instead of built are all defensible candidates and none of them are equivalent. Decide which qualify and hold each to the same evidence standard. Then decide the realization point: at launch, at first revenue, across a recognition schedule, or only once finance lowered a budget line or raised a forecast on the strength of it. Programs that never fix the realization point drift toward the earliest one.
• Attribution When the Product Would Have Shipped Anyway. This is the hardest fork and the one most often skipped. A partner contributes a component, a method or a piece of IP to a product that already had funding and a slot in the plan. Booking that product's full margin as a gain from open innovation is indefensible; booking nothing understates a real contribution. The workable rules are narrow: credit the delta the collaboration produced, meaning the schedule it pulled forward priced at a period of margin, or the internal development cost it displaced, or a share agreed at charter between the product owner and the program. Agree the rule before the product succeeds. The rule chosen afterwards is always the generous one.
• The Cost Boundary. Rule on each item explicitly: partner fees and awards, licensing payments, equity invested and whether it enters at cost or at a later mark, internal coordination time, legal and IP cost for agreements and filings, the program office and scouting function, and the evaluation spend on collaborations that never started. A boundary drawn around cash paid to outsiders yields a much higher ratio than one drawn around what the program consumed. Both conventions are in use. Only one can be in force at a time, and mixing them across years is the most common way this metric produces a trend that is not real.
• Failed and Abandoned Collaborations. If a terminated partnership leaves the denominator when someone closes its record, the program can improve this ratio by ending more partnerships. Keeping the failures in is the only version that describes the program rather than its survivors, and it is the only version that belongs next to a portfolio funding decision.
• The Lag and the Window. Open innovation spends early and returns late, later than comparable internal work, because a relationship has to be scouted, negotiated and contracted before any technical work begins. State the period the ratio covers, and state whether costs and gains are matched by the period in which each occurred or by the cohort of partnerships that started in a period. A calendar year ratio that charges this year's new agreements against products launched from agreements signed years ago is dividing one program by a different one. Cohort framing costs patience and is the only framing that lets the two halves refer to the same thing.
• Counterfactual or Incremental. A gain measured against doing nothing and a gain measured against the internal alternative are different numbers, and the second is the one a funding committee actually needs. The question in front of that committee is whether the external route beat building it inside, not whether it beat inaction. Very few trackers record the internal comparison, and it has to be captured at charter, because after the fact nobody can reconstruct what the in-house path would have cost.
• Portfolio Ratio or Average of Partnerships. Total gains over total cost is not the mean of per-partnership ratios. The mean is dominated by collaborations with tiny denominators and tells you about the best individual deals; the portfolio version tells you about the program. The formula on this page is the portfolio version, and the two will not agree.

Segmentation earns its place here more than usual. Cut first by partnership type: challenge and prize programs, joint development agreements, licensing-in, university sponsored research, startup equity and accelerator work, and consortium or cross-industry collaboration have different cost profiles, different lags and different claims on the resulting IP. Cut second by stage, because a discovery collaboration has no numerator yet and does not belong in the same calculation as one in scale-up; running stage cohorts separately stops exploratory work from being penalized for existing. Cut third by external partner class, since what can be contracted for, how ownership is split and who captures the gain all differ between a startup, a university, a supplier, a customer and a competitor inside a consortium. The KPI group's own guidance to segment partners by contribution type points at the same cut from the engagement side. What customers should not do is publish one company-wide figure assembled across all of it, because the mix shifts every year and the mix alone will move the ratio.

The instrumentation traps cluster in a few places, and most of them flatter the number.

Survivorship is the first. Most partnership trackers hold the collaborations that reached a deliverable; the ones that died in due diligence, stalled after a pilot or ended in a contract dispute get their records closed rather than counted. Building the ratio from completed partnerships answers what successful collaborations returned, which nobody asked. Run it from start cohorts and let them mature.

Double counting with internal R&D is the second, and it is close to universal in companies that run both. The same product improvement gets claimed by the open innovation program in its tracker and by the R&D function in its own, neither tracker knows about the other, and both report upward. Reconcile at the product level against a single register, and expect the sum of the claims to exceed the gain the company actually booked. The excess is the size of the attribution problem.

Soft benefits are the third. Learning, access to a technology or a market, option value on an early stage partner, and standing in a startup ecosystem are genuine reasons to run these programs. They are not gains in a ratio whose denominator is cash. Once they enter the numerator, the metric can be defended against any evidence, which is the same as saying it no longer measures anything. Track them, and track them somewhere else.

Near-zero-cost collaborations are the fourth. A university project with no fee attached, a customer co-development the customer funded, an idea that arrived free through an open challenge. A denominator near zero produces an enormous ratio, and one such entry can dominate an average of partnership ratios and distort even a portfolio figure in a small program. Set a floor, set a rule for what happens as recorded cost approaches zero, and at minimum book the internal time, which is never zero.

IP timing is the fifth. Patent cost lands when the filing and prosecution happen. A license, a sale or a defensive use may be years later, and an intangible acquired through a collaboration is amortized on a schedule chosen for accounting reasons that have nothing to do with when the work was done. The result is a ratio that moves in a year when no innovation happened, because a schedule turned over. If IP enters either side, state whether it enters at cash cost, at book value or at the value of an actual transaction, and never let one page mix the three.

One more, less exotic: charter estimates that were never replaced by realized figures. A tracker holding projected gains will report a portfolio built from forecasts, and forecast error in this domain runs one way. The same applies to figures supplied by the partner, who has an interest in the collaboration continuing.

What the metric cannot tell you is worth stating plainly. It cannot establish the counterfactual, so it cannot say whether the gain would have arrived without the partner. It cannot confirm that anything reached the income statement, since a ratio does not know whether a budget was cut or a forecast raised. It cannot size the opportunity left on the table, and it cannot tell a program whether it is the right size, because a smaller program usually posts a better ratio. It cannot price access, learning or option value, which for early stage collaborations may be most of the reason to do them. It cannot rank partners, since a portfolio figure averages over deals whose best and worst carry opposite lessons. And it does not travel between companies, because the cost boundary, the attribution rule and the window are all local choices, and two companies that made different choices produce numbers that only look comparable.

Common Pitfalls

Many organizations struggle with accurately measuring ROOII, leading to misguided strategic decisions.

• Failing to define clear objectives for open innovation can result in misaligned efforts. Without specific goals, teams may pursue initiatives that do not contribute to overall business outcomes, distorting the metric.
• Neglecting to track qualitative outcomes alongside quantitative returns can skew perceptions of success. Innovation often yields intangible benefits that are hard to measure but critical for long-term growth.
• Overlooking the importance of stakeholder engagement can hinder collaborative efforts. When key players are not involved, the quality of ideas and execution may suffer, negatively impacting returns.
• Relying solely on historical data without considering market changes can lead to poor forecasting accuracy. Innovation landscapes evolve rapidly, and outdated benchmarks may misguide investment decisions.

Improvement Levers

Enhancing ROOII requires a proactive approach to collaboration and continuous evaluation of innovation strategies.

• Establish clear metrics for evaluating open innovation initiatives to ensure alignment with strategic goals. This includes defining both financial and non-financial performance indicators that capture the full impact of innovation efforts.
• Foster a culture of collaboration by encouraging cross-functional teams to engage with external partners. This can lead to richer idea generation and improved operational efficiency.
• Implement regular reviews of innovation projects to assess progress and recalibrate strategies. Continuous monitoring can help identify successful initiatives and those needing adjustment.
• Invest in training for teams to enhance their skills in managing open innovation partnerships. Improved capabilities can lead to better collaboration and ultimately higher returns.

KPI Depot is trusted by consulting, strategy, finance, and analytics teams at leading organizations worldwide, including those listed below.

OKRs That Use Return on Open Innovation Investment

The Open Innovation Programs KPI group names this metric directly in its OKR material, under the objective to maximize the financial impact of open innovation on overall business growth. It appears there as a key result beside Open Innovation Revenue Contribution and Revenue from Co-Created Products, with the improvement attributed to better resource allocation rather than to more spend. The KPI group's rationale is that revenue driven through open innovation validates the approach as a core growth engine rather than a cost center, that this ratio imposes financial discipline on innovation spending, and that co-created product revenue captures the monetization of joint work. Customers adapting it should keep the key result directional, improve the return while the two revenue lines grow, rather than importing the illustrative target the worked example carries. A target for a ratio means nothing until the cost boundary underneath it is written down, and a team handed one will find the boundary that meets it.

That trio holds together for a reason worth understanding before anyone trims it. On its own, this ratio is among the easiest metrics in the KPI group to move without improving anything: sign fewer partnerships, leave coordination time and legal cost out of the denominator, or quietly drop terminated collaborations. Standing beside two revenue totals, the first route closes, because a shrinking program suppresses both of them. The accounting routes stay open, which is why the cost boundary and the attribution rule belong in the objective when it is set, not in the argument when it is scored.

The KPI group's second worked objective, accelerating the transition from external ideas to market-ready products, gives this metric a different job. Its key results run on Speed to Market for Open Innovation Projects, Open Innovation Project Completion Rate, External Ideas Adopted and External Innovation Conversion Rate, framed directionally: faster, higher, more, better converted. Every one of those can be bought. Adopt more ideas by loosening the screen, complete more projects by chartering easier ones, compress speed to market by paying a partner to accelerate. Attached to that objective as a guardrail rather than as a headline key result, this ratio asks what the speed cost. It pairs with the KPI group's guidance on Quality of Open Innovation Submissions, which is the one lever that lifts adoption and conversion without loading the denominator, since the cost avoided is the evaluation and contracting effort spent on ideas that were never viable.

One placement caution, drawn from the KPI group's third objective and its best practice guidance. That objective builds the partner ecosystem through Number of Active Open Innovation Partners, Percentage of Repeat Collaborators, Cultural Alignment with Partners and Open Innovation Challenge Participation. Recruiting partners and running larger challenges is denominator growth that arrives well ahead of any numerator, so this ratio does not belong as a key result on that objective in the same period; it would read as failure while the program does exactly what it was asked to do. The honest link runs the other way: the guidance on screening cultural alignment before onboarding and on segmenting partners by contribution type both reduce spend on collaborations that were never going to produce a gain, which is this metric's denominator working as intended. The same caution applies to Investment in Open Innovation at priority four, which the KPI group treats as a metric to grow. Setting it and this ratio as co-equal key results under one objective puts two owners in direct opposition.

See OKR Examples for Open Innovation Programs

Free Whitepaper

Want to achieve performance excellence in Open Innovation Programs? Download our in-depth whitepaper: Definitive Guide to Open Innovation Programs KPIs.

Download the Free Guide

KPI Categories

This KPI is associated with the following categories and industries in our KPI database: